Advocate Investing Services’s Amgen AMGN Stock Holding History

Advocate Investing Services’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$43.5K	Hold	120	–	–	0.03%	176
2026 Q1	$42.2K	Hold	120	–	–	0.04%	159
2025 Q4	$39.3K	Buy	+120	New	+$38.1K	0.04%	154

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Advocate Investing Services's AMGN Position: Q2 2026 in Review

Advocate Investing Services held its Amgen (AMGN) position steady in Q2 2026 at 120 shares worth $43.5K. The position accounts for 0.03% of the portfolio, ranked #176.

Advocate Investing Services first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Advocate Investing Services held 120 shares of Amgen worth $43.5K as of Q2 2026.
Advocate Investing Services left its Amgen share count unchanged in Q2 2026.
Amgen made up 0.03% of Advocate Investing Services's portfolio in Q2 2026, its #176 holding.
Advocate Investing Services first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Advocate Investing Services's 13F filing for Q2 2026, filed 29 Jul 2026.